STI Pharma Competitors and Similar CompaniesClear all

STI Pharma's competitors and similar companies include Takeda, Biocon, Takeda Oncology and Kyowa Kirin.
STI Pharma
STI Pharma
STI Pharma is a specialty pharmaceutical company with a focus on oncology.
Takeda
Takeda
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
Biocon
Biocon
Biocon is a company that develops and manufactures biopharmaceutical products.
Takeda Oncology
Takeda Oncology
Takeda Oncology is a biopharmaceutical company developing medicines for the treatment of oncology and inflammation diseases.
Kyowa Kirin
Kyowa Kirin
Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
Founding Date
Founding Date
2008
Founding Date
1781
Founding Date
1978
Founding Date
1993
Founding Date
2008
Type
Type
Private
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Newtown, US HQ
Menomonee Falls, US
Milwaukee, US
Locations
Tokyo, JP HQ
Buenos Aires, AR
The Rocks, AU
Linz, AT
Wien, AT
Wien, AT
Lessines, BE
see more
Locations
Bengaluru, IN HQ
Bengaluru, IN
Nanakramguda, IN
Dublin, IE
Kuala Lumpur, MY
Puchong, MY
Delémont, CH
see more
Locations
Cambridge, US HQ
Locations
Tokyo, JP HQ
Sydney, AU
Shanghai, CN
Prague, CZ
Tampere, FI
Düsseldorf, DE
Hong Kong, HK
see more
Employees
Employees
8
Employees
47,4554% decrease
Employees
16,5612% increase
Employees
1,6441% decrease
Employees
5,669
Valuation ($)
Valuation ($)
N/A
Valuation ($)
43.7 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
8.8 b

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
¥4.6t (FY, 2025)
Revenue (est.)
₹167.8b (FY, 2026)
Revenue (est.)
N/A
Revenue (est.)
¥496.8b (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
¥818.8b (FY, 2025)
Cost of goods
₹56.9b (FY, 2026)
Cost of goods
N/A
Cost of goods
¥114.3b (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
¥3.8t (FY, 2025)
Gross profit
₹115.8b (FY, 2026)
Gross profit
N/A
Gross profit
¥383.4b (FY, 2025)
Net income
Net income
N/A
Net income
¥108.1b (FY, 2025)
Net income
₹3.7b (FY, 2026)
Net income
N/A
Net income
¥67b (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Takeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease

Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.

View company
Biocon
HQ
Bengaluru, IN
Employees
16,561↑ 2% increase

Biocon is a company that develops and manufactures biopharmaceutical products.

View company
Takeda Oncology
HQ
Cambridge, US

Takeda Oncology is a biopharmaceutical company developing medicines for the treatment of oncology and inflammation diseases.

View company
Kyowa Kirin
HQ
Tokyo, JP
Employees
5,669

Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.

View company